Stefanie H. Mueller

Stefanie H. Mueller

Auto-generated profile, based on publicly available information

Stefanie H. Mueller

MIT CSAIL, Cambridge, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Brain Research
Verified
Journal Article
Closed access
FHFranziska Hopfner
Franziska Hopfner
AKAxel Künstner
Axel Künstner
SMStefanie H. Müller
Stefanie H. Müller
SKSven Künzel
Sven Künzel
KZKirsten E. Zeuner
Kirsten E. Zeuner
GKGregor Kuhlenbäumer
Gregor Kuhlenbäumer

23 March 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SMStefanie H. Mueller
Stefanie H. Mueller
AFAnna Färber
Anna Färber
HPHarald Prüss
Harald Prüss
NMNico Melzer
Nico Melzer
KGKristin S. Golombeck
Kristin S. Golombeck
O(on behalf of the German Network for Research on Autoimmune Encephalitis (GENERATE)
on behalf of the German Network for Research on Autoimmune Encephalitis (GENERATE)

20 October 2016 in Brain
Verified
Journal Article
Open access
PDF file
SMStefanie H. Müller
Stefanie H. Müller
SGSimon L. Girard
Simon L. Girard
FHFranziska Hopfner
Franziska Hopfner
NMNancy Merner
Nancy Merner
CBCynthia V. Bourassa
Cynthia V. Bourassa
GRGuy A Rouleau
Guy A Rouleau
We conducted a genome-wide association study of essential tremor, a common movement disorder characterized mainly by a postural and kinetic tremor of the upper extremities. Twin and family history studies show a high heritability for essential tremor. The molecular genetic determinants of essential tremor are unknown. We included 2807 patients and 6441 controls of European descent in our two-stage genome-wide association study. The 59 most significantly disease-associated markers of the discovery stage were genotyped in the replication stage. After Bonferroni correction two markers, one (rs10937625) located in the serine/threonine kinase STK32B and one (rs17590046) in the transcriptional coactivator PPARGC1A were associated with essential tremor. Three markers (rs12764057, rs10822974, rs7903491) in the cell-adhesion molecule CTNNA3 were significant in the combined analysis of both stages. The expression of STK32B was increased in the cerebellar cortex of patients and expression quantitative trait loci database mining showed association between the protective minor allele of rs10937625 and reduced expression in cerebellar cortex. We found no expression differences related to disease status or marker genotype for the other two genes. Replication of two lead single nucleotide polymorphisms of previous small genome-wide association studies (rs3794087 in SLC1A2, rs9652490 in LINGO1) did not confirm the association with essential tremor.

15 October 2012 in Developmental Medicine & Child Neurology
Verified
Journal Article
Closed access
PDF file
SASilke Appenzeller
Silke Appenzeller
IHIngo Helbig
Ingo Helbig
USUlrich Stephani
Ulrich Stephani
MHMartin Häusler
Martin Häusler
GKGerhard Kluger
Gerhard Kluger
ABAndreas VAN Baalen
Andreas VAN Baalen

1 July 2017 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
WCWei Chen
Wei Chen
FHFranziska Hopfner
Franziska Hopfner
SSSilke Szymczak
Silke Szymczak
OGOliver Granert
Oliver Granert
SMStefanie H. Müller
Stefanie H. Müller
GDGünther Deuschl
Günther Deuschl

1 December 2017 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
ASAli S. Shalash
Ali S. Shalash
TRThomas W. Rösler
Thomas W. Rösler
SMStefanie H. Müller
Stefanie H. Müller
MSMohamed Salama
Mohamed Salama
GDGünther Deuschl
Günther Deuschl
GHGünter U. Höglinger
Günter U. Höglinger
Objective: To elucidate the genetic cause of an Egyptian family with dopa-responsive dystonia (DRD), a childhood-onset dystonia, responding therapeutically to levodopa, which is caused by mutations in various genes. Methods: Rare variants in all coding exons of GCH1 were excluded by Sanger sequencing. Exome sequencing was applied for 1 unaffected and 2 affected family members. To investigate the functional consequences of detected genetic variants, urinary sepiapterin concentrations were determined by high-performance liquid chromatography. Results: A heterozygous rare nonsynonymous variant in exon 1 of sepiapterin reductase (SPR, c.207C>G, p.Asp69Glu) was found in all affected family members. Urinary concentrations of sepiapterin were above the standard of normal controls in most SPR mutation carriers, suggesting functional biochemical consequences of the mutation. Variant filtering of all genes involved in the tetrahydrobiopterin pathway, required for levodopa synthesis, revealed an additional common variant in dihydrofolate reductase (DHFR, rs70991108). The presence of both variants was significantly stronger associated with the biochemical abnormality and the clinical disease state as opposed to 1 variant only. Conclusions: The rare SPR mutation can cause autosomal dominant DRD with incomplete penetrance. The common DHFR variant might have synergistic effects on production of tetrahydrobiopterin and levodopa, thereby increasing penetrance.